Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.

Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee MD, Van Erp E.

Am J Obstet Gynecol. 2005 Aug;193(2):352-60.

PMID:
16098854
2.

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.

Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.

Psychosom Med. 2004 Sep-Oct;66(5):707-13.

PMID:
15385695
3.

Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD.

J Clin Psychiatry. 2008 Jun;69(6):991-8.

PMID:
18517289
4.
5.

Controlled-release paroxetine in the treatment of patients with social anxiety disorder.

Lepola U, Bergtholdt B, St Lambert J, Davy KL, Ruggiero L.

J Clin Psychiatry. 2004 Feb;65(2):222-9.

PMID:
15003077
6.

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.

J Clin Psychiatry. 2002 Jul;63(7):577-84.

PMID:
12143913
7.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
8.

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H.

J Clin Psychiatry. 2005 Jun;66(6):769-73.

PMID:
15960573
9.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
11.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
12.

Symptom-onset treatment for women with premenstrual dysphoric disorder.

Yonkers KA, Holthausen GA, Poschman K, Howell HB.

J Clin Psychopharmacol. 2006 Apr;26(2):198-202.

PMID:
16633152
13.
14.

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

Rapaport MH, Lydiard RB, Pitts CD, Schaefer D, Bartolic EI, Iyengar M, Carfagno M, Lipschitz A.

J Clin Psychiatry. 2009 Jan;70(1):46-57. Epub 2008 Oct 7.

PMID:
19026248
15.

History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA.

World J Biol Psychiatry. 2009;10(4 Pt 2):435-41. doi: 10.1080/15622970902789155.

PMID:
19382010
16.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
17.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
18.

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.

Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL, Jiang W.

Am J Med. 2007 May;120(5):448-54.

PMID:
17466657
19.

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S.

Obstet Gynecol. 2002 Sep;100(3):435-44.

PMID:
12220761
20.

Venlafaxine in the treatment of premenstrual dysphoric disorder.

Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV.

Obstet Gynecol. 2001 Nov;98(5 Pt 1):737-44.

PMID:
11704162

Supplemental Content

Support Center